Algae Dynamics Corp. (ADYNF) Collaborates with University of Western Ontario

 

  • Research finds that higher levels of the brain chemical GABA can reverse negative effects such as schizophrenia and depression
  • Professor Steven Laviolette, who spearheaded the study, hopes that GABA-increasing cannabinoid compounds developed with industrial partners from this research could lead to clinical trials “in the next few years”
  • Algae Dynamics Corp. has signed a collaborative agreement with the University of Western Ontario, giving the company the patent rights to any drugs developed as a result of research

Algae Dynamics Corp. (OTCQB: ADYNF) is in a collaboration agreement with the University of Western Ontario (now rebranded as Western University), which is making international news with its recent study in Nature Scientific Reports (http://nnw.fm/aJ7Oh). The study found that the negative effects on the adolescent brain from chronic use of tetrahydrocannabinol (THC)-rich marijuana can be reversed by using compounds which increase the amounts of GABA, a chemical and neurotransmitter in the brain.

The article in Nature Scientific Reports is titled “Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.” The results have been…

Read More >>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

India Globalization Capital, Inc. (NYSE: IGC) Preparing to Bring Cannabis Combo Therapy for Alzheimer’s Disease to Trials

 

  • Four drug candidates in the pipeline
  • Potential sales of Alzheimer’s drugs run to billions
  • Hyalolex heading for clinical trials

India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials for four drug candidates that treat a variety of debilitating conditions. At the head of the line is Hyalolex, aimed at reducing the buildup of amyloid β-peptide (Aβ) plaques on neurons in the brain, a process that causes the crippling cognitive complaint known as Alzheimer’s disease.

Alzheimer’s afflicts more than five million Americans, and, so far, no effective cure for this form of dementia has been found. However, the FDA has approved five medications to treat its symptoms. IGC is hoping to make Hyalolex the sixth. The drug works through a molecular pathway that allows low doses of THC to bind to Aβ plaques and so prevent them from aggregating on neurons. IGC has entered into a definitive license agreement…

Read More >>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – GB Sciences, Inc. (GBLX) Forges Innovative Partnership with LSU AgCenter to Advance Understanding of Cannabis

GB Sciences, Inc. (OTCQB: GBLX) and Louisiana State University (“LSU”) AgCenter recently announced an agreement with GB Sciences Louisiana, LLC, a wholly owned subsidiary of GB Sciences, Inc., to produce medical cannabis products for qualifying patients. The agreement, conducted under compliance with the Alison Neustrom Act, will allow GB Sciences to produce medical cannabis under the AgCenter’s license. In a news release, GB Sciences, Inc. stated that the agreement is “historic” and creates a formidable partnership. GB Sciences is a publicly traded cannabis company firmly rooted in science. This partnership with LSU, a major research university, is dedicated to advancing the understanding of the cannabis plant and offering cannabis-based medicines to patients of Louisiana.

To view the full article, visit http://nnw.fm/9wYX8

About GB Sciences, Inc.

GB Sciences, Inc. (GBLX) is a diverse cannabis company focused on standardized cultivation and production methods, as well as biopharmaceutical research and development. The company’s goal is to create safe, standardized pharmaceutical-grade cannabinoid therapies that target a variety of medical conditions. For more information, visit www.GBSciences.com

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Moxian, Inc. (NASDAQ: MOXC) Shareholders to Vote on Seven Directors at Annual Meeting on September 29 in Beijing

 

  • Director nominees include Liu Shu Juan, CEO of Shewn International Group and financial controller of Shanghai Shewn Wine Co.
  • Moxian is expected to formalize joint venture agreement with Shewn International Group by end of September 2017
  • Joint ventures are part of Moxian’s new strategy to enter major markets in China more quickly and at lower cost

Moxian, Inc. (NASDAQ: MOXC) will nominate seven directors to its board for shareholders at its annual meeting on September 29, 2017, in Beijing, China (http://nnw.fm/2mJhT). Among the seven is Liu Shu Juan, chief executive officer of Shewn International Group, Inc. and financial controller of Shanghai Shewn Co., Ltd., the company’s primary operator in China.

Liu has been a Moxian board member since August 2017. Moxian has an agreement of understanding with Shewn International Group, Inc., expected to be finalized by the end of September 2017, for a joint venture as part of a new marketing strategy for Moxian. The Shanghai-based company plans a series of joint ventures to enable it to penetrate key markets in China more quickly and at a lower cost. James Mengdong Tan, president and chief executive officer of Moxian, told Crystal Equity Research that he has…

Read More >>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 21, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage:

DGJI 26.13% – News: Begins trading on the OTCQX® Best Market

NVFY 17.66% – News: Diamond Sofa named as one of the top five Asian American Brands by US News Express

MRIC 13.18% – News: Presenting at the 2017 MicroCap Conference on October 5

LTEA 9.95% – News: Becomes the official Iced Tea of Barclays Center

IZEA 8.57% – News: Launches first Augmented Sponsorship™ campaign

LPCN 5.00% – News: Reports positive motions decision by USPTO in interference against Clarus

ARHH 4.74% – News: Opens the market at TSX Venture Exchange

KGJI 3.28% – News: Schedules its 2017 annual meeting of stockholders for December 8

MKGI 2.86% – News: Presenting at the Third Annual Robins Equity Research Roundup on September 26

CHFS 2.76% – News: Presenting at the Ladenburg Thalmann 2017 Healthcare Conference on September 26

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Tantech Holdings Ltd.’s (NASDAQ: TANH) Subsidiary Secures $20M Electric Vehicle Order

Tantech Holdings (NASDAQ: TANH) this morning said that its 70% owned subsidiary, Suzhou E Motors Buses Co., Ltd., has signed sales contracts for its electric vans and buses worth approximately $20 million. Per the contracts, Zhenjiang Baichuan New Energy Automobile Co., Ltd. intends to purchase 450 all-electric vans and 10 all-electric buses from Tantech with a projected unit sales price of U.S. $43,077. In addition to the unit sales price, Tantech may be eligible to receive Chinese government subsidies for electric car sales. Tantech is expecting to deliver the order by the end of 2017. “In addition to manufacturing a series of bamboo charcoal products, Tantech has entered the electric vehicle industry through the recent acquisition of Suzhou E Motor. This new sales contract, along with the recent MIIT approval of two of our EV models, laid a solid foundation for us to gain market share in the fast growing Chinese EV segment,” Tantech chairman and chief executive officer Zhengyu Wang stated in the news release.

To view the full press release, visit: http://nnw.fm/Ik1Cy

About Tantech Holdings Ltd.

Established in 2001 and headquartered in Lishui City, Zhejiang Province, China, Tantech Holdings Ltd., together with its subsidiaries, develops and manufactures bamboo-based charcoal products, including a variety of branded consumer products and electric double-layer capacitor (“EDLC”) carbon products for industrial energy applications. The company aims to transform itself from a bamboo-based charcoal products producer to a vertically integrated company along the EDLC Carbon – power battery – specialty new energy vehicle value chain. For more information, please visit: www.tantechholdings.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Onconova Therapeutics, Inc. (NASDAQ: ONTX) Enters Strategic Collaboration with Cellectar Biosciences, Inc. (NASDAQ: CLRB) to Develop New PDCs

Shares of Onconova Therapeutics (NASDAQ: ONTX) are up 6% after the company this morning said it has entered into a strategic collaboration with Cellectar Biosciences (NASDAQ: CLRB) to develop new phospholipid drug conjugates (PDCs). The companies intend to combine Cellectar’s patented phospholipid ether delivery platform with select proprietary compounds or payloads from Onconova’s early stage product pipeline. Per the terms of the collaboration, Onconova will provide several compounds to Cellectar, which will then link to its PDC platform to create new, more precisely targeted antitumor agents. “We are focused on optimizing the delivery of our therapeutic compounds in the battle against Myelodysplastic Syndrome and a variety of cancers. As such, we are excited to collaborate with Cellectar and leverage their PDC platform, which we believe can improve the targeting of our molecules directly to the cancer, in addition to extending the patent coverage of these drug candidates,” Onconova Therapeutics president and CEO Ramesh Kumar, Ph.D., stated in the news release.

To view the full press release, visit: http://nnw.fm/qRa6g

About Cellectar Biosciences, Inc.

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar’s PDC platform is based on the company’s proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. Cellectar’s PDC pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. The company’s lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. CLR 131 has been designated as an orphan drug by the US FDA and is currently being evaluated in a phase 1 clinical study in patients with relapsed or refractory multiple myeloma and a phase 2 clinical study to assess efficacy in a range of B-cell malignancies. The company is also developing proprietary PDCs for targeted delivery of chemotherapeutics and has several preclinical stage product candidates, and plans to expand its PDC chemotherapeutic pipeline through both in-house and collaborative R&D efforts. For more information, please visit www.cellectar.com.

About Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc. is a phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova’s lead candidate, is a proprietary phase 3 small molecule agent, which the company believes blocks cellular signaling by targeting RAS effector pathways. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in the clinical stage and several pre-clinical programs. Advanced clinical trials with the company’s lead compound, rigosertib, are aimed at what the company believes are unmet medical needs of patients with MDS. For more information, please visit www.onconova.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com